43 results on '"Hisakane, Kakeru"'
Search Results
2. Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia
3. Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.
4. MO1-4 Efficacy of immune checkpoint inhibitors plus chemotherapy for TTF-1-negative non-squamous non-small cell lung cancer
5. Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study
6. Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer.
7. Thyroid transcription factor-1 (TTF-1) expression and the efficacy of combination therapy with immune checkpoint inhibitors and cytotoxic chemotherapy in non-squamous non-small cell lung cancer
8. Development of eosinophilic pneumonia from eosinophilic bronchiolitis without asthma: A case report
9. Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer
10. The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer
11. A Case of Pseudo-progression-like Pleurisy After Combined Treatment with Nivolumab and Ipilimumab for Lung Adenocarcinoma
12. Black pleural effusion caused by a pancreaticopleural fistula associated with autoimmune pancreatitis: A case report
13. Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
14. A Case of Fulminant Type 1 Diabetes Mellitus After the Administration of Durvalumab for Small-cell Lung Cancer
15. Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
16. Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chemotherapy: A multicenter retrospective study
17. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma
18. Carboplatin plus nanoparticle albumin‑bound paclitaxel for the treatment of thymic carcinoma
19. A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
20. Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET/CT: A case report
21. Exosome‐derived miR ‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition inEGFRmutant non‐small cell lung cancer cells
22. PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma
23. A Novel Molecular Target in EGFR-Mutant Non-Small Cell Lung Cancer Treated With a Combination of Osimertinib and Pemetrexed
24. Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single‐arm study
25. Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer
26. Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells.
27. Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression
28. Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017
29. Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer
30. Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
31. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease
32. Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report
33. Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer.
34. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung
35. The ratio of cancer cells to stroma after induction therapy in the treatment of non-small cell lung cancer
36. Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.
37. First-line immune checkpoint inhibitors alone or in combination with chemotherapy in real-life elderly patients with advanced non-small cell lung cancer (NEJ057).
38. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma
39. Immunofluorescence Microscopy of Epidermal Desmosome in Molecular Anatomy Course at Nippon Medical School
40. Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma.
41. Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion.
42. A remarkable response to combination chemotherapy with nivolumab and ipilimumab in a patient with primary pulmonary choriocarcinoma: a case report.
43. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.